1034618-02-4

Basic information

• Product Name: 5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamine
• Synonyms: 5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamine
• CAS NO: 1034618-02-4
• Molecular Weight: 275.274
• Mol File: 1034618-02-4.mol

Chemical Properties

• CAS DataBase Reference: 5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamine(1034618-02-4)
• EPA Substance Registry System: 5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamine(1034618-02-4)

Safety Data

• Hazardous Substances Data: 1034618-02-4(Hazardous Substances Data)

Upstream product

• 109-01-3 1-methyl-piperazine 
• 886762-08-9 5-bromo-2-(trifluoromethoxy)aniline 

Downstream Products

• 1034618-00-2 N-[5-(4-methyl-piperazin-1-yl)-2-trifluoromethoxy-phenyl]-guanidine 
• 1137468-17-7 1-[3-iodo-4-(trifluoromethoxy)phenyl]-4-methylpiperazine 
• 1137468-22-4 2-{2-[5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamino]pyrimidin-4-yl}-4-oxo-1-(2,2,2-trifluoroethyl)-1,4,6,7-tetrahydropyrrolo[3,2-c]pyridine-5-carboxylic acid tert-butyl ester 
• 1159994-47-4 (R)-8-cyclopentyl-7-ethyl-5-methyl-2-[5-(4-methyl-piperazin-1-yl)-2-trifluoromethoxy-phenylamino]-7,8-dihydro-5H-pteridin-6-one 
• 1034614-67-9 1-methyl-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide 
• 1034615-39-8 8-[5-(4-methylpiperazin-1-yl)-2-trifluoromethoxyphenylamino]-1-trityl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide 

Relevant articles and documents

PYRAZOLO-QUINAZOLINES

The present invention relates to pyrazolo-quinazolines, characterized by an ortho-substituted-arylamino, heterocyclylamino- or C3-C7 cycloalkylamino residue at 8 position and an aryl, heterocyclyl or C3-C7 cyclo

SUBSTITUTED PYRROLO-PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

Substituted pyrrolo-pyrimidine derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the inv

SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS KINASE INHIBITORS

Pyrazolo-quinazoline derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may